NEW YORK, July 9, 2022 /PRNewswire/ —
WHY: Rosen Law Firm, a global investor rights law firm, is providing an important reminder to purchasers of securities of Axsome Therapeutics, Inc. (NASDAQ: AXSM) between December 30, 2019 and April 22, 2022 inclusive (the “Collection Period”) July 12, 2022 deadline for lead plaintiff,
SO WHAT: If you purchased Axsome securities during the Class Period, you may be entitled to compensation without payment of expenses or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To participate in the Axsome Class Action, contact or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] or [email protected] for information about the Class Action. A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court by July 12, 2022 at the latestA lead plaintiff is a representative party acting on behalf of other group members in conducting the litigation.
WHY ROSES LAW: We encourage investors to select qualified advisors with a track record in leadership positions. Frequently, companies that issue notices do not have comparable experience, resources, or meaningful recognition from peers. Many of these law firms do not actually conduct securities class actions, but are merely intermediaries who refer clients or work with law firms who actually hear the cases. Be wise in choosing a lawyer. The Rosen Law Firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivatives litigation. Rosen Law Firm has achieved the largest-ever securities class-action settlement against a Chinese company. Rosen Law Firm was ranked #1 in 2017 by ISS Securities Class Action Services for the number of securities class action settlements. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named Titan of Plaintiffs’ Bar by Act360. Many of the firm’s attorneys are recognized by Lawdragon and Super Lawyers.
CASE DETAILS: According to the complaint, the defendants made false and/or misleading statements and/or failed to disclose the following: (1) Axsome’s chemistry, manufacturing and control practices (“CMC”) were deficient with respect to AXS-07 and its manufacturing process; (2) as a result, it was unlikely that Axsome would submit the AXS-07 New Drug Application (“NDA”) within the originally stated timeline; (3) the foregoing CMC issues remained unresolved at the time the US Food and Drug Administration (“FDA”) reviewed the AXS-07 NDA; (4) accordingly, it was unlikely that the FDA would approve the AXS-07 NDA; (5) as a result of all of this, Axsome had overstated the regulatory and commercial prospects of AXS-07; and (6) as a result, Axsome’s public statements were materially false and misleading at all relevant times. As the true details emerged, the lawsuit alleges that investors suffered damage.
To participate in the Axsome Class Action, contact or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] or [email protected] for information about the Class Action.
No class was certified. Until a class is certified, you will not be represented by an attorney unless you retain one. You can choose a lawyer of your choice. You can also remain absent and do nothing at this point. An investor’s ability to participate in a potential future recovery is not contingent on its serving as lead plaintiff.
Follow us for updates on LinkedIn: on Twitter: or on Facebook:
lawyer advertising. Previous results do not guarantee a similar result.
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Law Firm of Rosen, PA
275 Madison Avenue, 40th floor
New York, New York 10016
Phone: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
SOURCE Law Firm Rosen, PA